To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

13.50a day ago
14.00a day ago
arrow

LOWER/UPPER CIRCUITS

11.11
16.65
arrow
Gennex Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 61.9%, in the last year to ₹148.33 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 37.57% in the last year to ₹18.12 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 19.32, lower than its sector PE ratio of 43.7.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 39.72%
Net profit growth 5Y CAGR : 42.77%
Gennex Laboratories Ltd is engaged in the manufacture and export of bulk drugs and intermediates.The product range of the company includes Guaiphenesin Methocarbamol Fluconazole and Phenazopyridine.
personal

Grow your wealth with more research recommendations

+91